These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
536 related articles for article (PubMed ID: 24129463)
1. Quality of life after PCI vs CABG among patients with diabetes and multivessel coronary artery disease: a randomized clinical trial. Abdallah MS; Wang K; Magnuson EA; Spertus JA; Farkouh ME; Fuster V; Cohen DJ; JAMA; 2013 Oct; 310(15):1581-90. PubMed ID: 24129463 [TBL] [Abstract][Full Text] [Related]
2. Quality of life after PCI with drug-eluting stents or coronary-artery bypass surgery. Cohen DJ; Van Hout B; Serruys PW; Mohr FW; Macaya C; den Heijer P; Vrakking MM; Wang K; Mahoney EM; Audi S; Leadley K; Dawkins KD; Kappetein AP; N Engl J Med; 2011 Mar; 364(11):1016-26. PubMed ID: 21410370 [TBL] [Abstract][Full Text] [Related]
3. Stroke Rates Following Surgical Versus Percutaneous Coronary Revascularization. Head SJ; Milojevic M; Daemen J; Ahn JM; Boersma E; Christiansen EH; Domanski MJ; Farkouh ME; Flather M; Fuster V; Hlatky MA; Holm NR; Hueb WA; Kamalesh M; Kim YH; Mäkikallio T; Mohr FW; Papageorgiou G; Park SJ; Rodriguez AE; Sabik JF; Stables RH; Stone GW; Serruys PW; Kappetein AP J Am Coll Cardiol; 2018 Jul; 72(4):386-398. PubMed ID: 30025574 [TBL] [Abstract][Full Text] [Related]
4. Quality of Life After Surgery or DES in Patients With 3-Vessel or Left Main Disease. Abdallah MS; Wang K; Magnuson EA; Osnabrugge RL; Kappetein AP; Morice MC; Mohr FA; Serruys PW; Cohen DJ; J Am Coll Cardiol; 2017 Apr; 69(16):2039-2050. PubMed ID: 28427580 [TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial. Magnuson EA; Farkouh ME; Fuster V; Wang K; Vilain K; Li H; Appelwick J; Muratov V; Sleeper LA; Boineau R; Abdallah M; Cohen DJ; Circulation; 2013 Feb; 127(7):820-31. PubMed ID: 23277307 [TBL] [Abstract][Full Text] [Related]
6. Do differences in repeat revascularization explain the antianginal benefits of bypass surgery versus percutaneous coronary intervention?: implications for future treatment comparisons. Arnold SV; Magnuson EA; Wang K; Serruys PW; Kappetein AP; Mohr FW; Cohen DJ; Circ Cardiovasc Qual Outcomes; 2012 May; 5(3):267-75. PubMed ID: 22496114 [TBL] [Abstract][Full Text] [Related]
7. Coronary Artery Bypass Surgery Versus Drug-Eluting Stent Implantation for Left Main or Multivessel Coronary Artery Disease: A Meta-Analysis of Individual Patient Data. Lee CW; Ahn JM; Cavalcante R; Sotomi Y; Onuma Y; Suwannasom P; Tenekecioglu E; Yun SC; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ JACC Cardiovasc Interv; 2016 Dec; 9(24):2481-2489. PubMed ID: 28007199 [TBL] [Abstract][Full Text] [Related]
8. Everolimus-Eluting Stents or Bypass Surgery for Multivessel Disease in Diabetics: The BEST Extended Follow-Up Study. Kim H; Kang DY; Ahn JM; Lee J; Choi Y; Hur SH; Park HJ; Tresukosol D; Kang WC; Kwon HM; Rha SW; Lim DS; Jeong MH; Lee BK; Huang H; Lim YH; Bae JH; Kim BO; Ong TK; Ahn SG; Chung CH; Park DW; Park SJ; JACC Cardiovasc Interv; 2023 Oct; 16(19):2412-2422. PubMed ID: 37821187 [TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial. Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW; Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960 [TBL] [Abstract][Full Text] [Related]
10. Quality-of-Life After Everolimus-Eluting Stents or Bypass Surgery for Left-Main Disease: Results From the EXCEL Trial. Baron SJ; Chinnakondepalli K; Magnuson EA; Kandzari DE; Puskas JD; Ben-Yehuda O; van Es GA; Taggart DP; Morice MC; Lembo NJ; Brown WM; Banning A; Simonton CA; Kappetein AP; Sabik JF; Serruys PW; Stone GW; Cohen DJ; J Am Coll Cardiol; 2017 Dec; 70(25):3113-3122. PubMed ID: 29097293 [TBL] [Abstract][Full Text] [Related]
11. Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trial. Dangas GD; Farkouh ME; Sleeper LA; Yang M; Schoos MM; Macaya C; Abizaid A; Buller CE; Devlin G; Rodriguez AE; Lansky AJ; Siami FS; Domanski M; Fuster V; J Am Coll Cardiol; 2014 Sep; 64(12):1189-97. PubMed ID: 25236509 [TBL] [Abstract][Full Text] [Related]
12. Everolimus-eluting stents or bypass surgery for multivessel coronary disease. Bangalore S; Guo Y; Samadashvili Z; Blecker S; Xu J; Hannan EL N Engl J Med; 2015 Mar; 372(13):1213-22. PubMed ID: 25775087 [TBL] [Abstract][Full Text] [Related]
13. SYNTAX Score in Patients With Diabetes Undergoing Coronary Revascularization in the FREEDOM Trial. Esper RB; Farkouh ME; Ribeiro EE; Hueb W; Domanski M; Hamza TH; Siami FS; Godoy LC; Mathew V; French J; Fuster V J Am Coll Cardiol; 2018 Dec; 72(23 Pt A):2826-2837. PubMed ID: 30522646 [TBL] [Abstract][Full Text] [Related]
14. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. Kapur A; Hall RJ; Malik IS; Qureshi AC; Butts J; de Belder M; Baumbach A; Angelini G; de Belder A; Oldroyd KG; Flather M; Roughton M; Nihoyannopoulos P; Bagger JP; Morgan K; Beatt KJ J Am Coll Cardiol; 2010 Feb; 55(5):432-40. PubMed ID: 20117456 [TBL] [Abstract][Full Text] [Related]
15. Long-Term Mortality After Coronary Revascularization in Nondiabetic Patients With Multivessel Disease. Chang M; Ahn JM; Lee CW; Cavalcante R; Sotomi Y; Onuma Y; Tenekecioglu E; Han M; Park DW; Kang SJ; Lee SW; Kim YH; Park SW; Serruys PW; Park SJ J Am Coll Cardiol; 2016 Jul; 68(1):29-36. PubMed ID: 27364047 [TBL] [Abstract][Full Text] [Related]